Details for New Drug Application (NDA): 060582
✉ Email this page to a colleague
NDA 060582 describes NEOSPORIN, which is a drug marketed by Glaxosmithkline and Monarch Pharms and is included in three NDAs. Additional details are available on the NEOSPORIN profile page.
The generic ingredient in NEOSPORIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.
The generic ingredient in NEOSPORIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 060582
| Tradename: | NEOSPORIN |
| Applicant: | Monarch Pharms |
| Ingredient: | gramicidin; neomycin sulfate; polymyxin b sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AT | RLD: | No | ||||
Complete Access Available with Subscription
